Use Less Sample in Your Immunoassays5月 2nd, 2017 / Hilary Graham
Generate more discoveries
How do you know that you are getting the most insights from your investment of sample, time, and reagents?
If you are currently using a low throughput method, such as Western blot, ELISA, or real-time polymerase chain reaction (PCR) consider switching to a multiplex assay format.
Most scientists find value in adopting xMAP® multiplexing technology when they are evaluating as few as three targets, although the platform can detect up to 500 protein or oligonucleotide analytes from a single aliquot of sample in a single reaction well.
The xMAP multiplexing platform is composed of reagents and detection instruments:
- xMAP microspheres are a family of 500 fluorescently dyed carboxylated polystyrene microspheres that act as both the surface for the solution phase assay and the spectral identifier that the instrument detects. The open architecture of xMAP Technology enables users to build custom multiplex assays or select from a broad menu commercially available kits.
- Luminex offers three xMAP instruments to meet your experimental, budget, throughput, and multiplexing needs.
Ready to get started? Have a business manager contact you today.